Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland

Hepatitis C viral infection is common among opioid addicts in Zurich, Switzerland. The majority undergoes a maintenance treatment with methadone, heroin or buprenorphine. While stabilized by an opioid maintenance treatment (OMT)chronic hepatitis C can be treated with pegylated interferon plus ribavirin. As not sufficiently known, the results are comparable to the results of the treatment of nonaddicts.

Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C. If not, why are they not adequately investigated and treated? Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich. The patients files are revised and the involved doctors are asked through a structured interview.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatitis C, Chronic Blood-Borne Infections Chemically-Induced Disorders Chronic Disease Communicable Diseases Digestive System Diseases Disease Attributes Flaviviridae Infections Hepatitis Hepatitis C Hepatitis, Chronic Hepatitis, Viral, Human Infections Liver Diseases Mental Disorders Narcotic-Related Disorders Opioid-Related Disorders Pathologic Processes Pathological Conditions, Signs and Symptoms RNA Virus Infections Substance Abuse Treatment Centers Substance-Related Disorders Virus Diseases

Sex eligibility

All sexes

Study type

Observational

About this study

www.seidenberg.ch/hepcop.pdf

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Medical practices and clinics involved in opioid maintenance treatment in the Kanton of Zurich, Switzerland

Sponsors and collaborators

Lead sponsor

Seidenberg, Arztpraxis A., M.D.

Indiv

Collaborators

University of Zurich

Registry information

Official study title

Hepatitis C Bei Opioidabhängigen in Der Praxis, Eine Querschnittsuntersuchung

Acronym: HepCOP

Important dates

Study start: 2007
Study completion: 2007
First posted: May 16, 2007
Registry last updated: Feb 16, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed